Levofloxacin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D

## Levofloxacin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D: Overview

This comparison examines the pharmacological differences between **Levofloxacin** and **Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D**.

## Mechanism of Action

**Levofloxacin**: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

## Pharmacokinetics

**Half-life**: Levofloxacin — 6-8 hours; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

## Chemical Properties

**Molecular Formula**: Levofloxacin — C18H20FN3O4; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

**Molecular Weight**: Levofloxacin — 361.3680 g/mol; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

**Type**: Levofloxacin — Small molecule; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — Vaccine component.